Internal Medicine, Hematology & Oncology · Elizabethtown, KY
NPI
1972585883
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1107 Woodland Dr, Suite 105
Elizabethtown, KY, 42701
Phone (270) 769-6665
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
65,803 services
Medicare patients, 2024
486
Average age 75
Drug cost, 2024
$2.2M
2,647 prescriptions
Company payments, 2025
$2,957
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yusuf K Deshmukh was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 2,380 times for 25 patients. In total Yusuf K Deshmukh billed 65,803 services in 79 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,380 | 25 | $0.09 | $216 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,132 | 25 | $0.07 | $159 |
| 85025 Blood Count | Office | 1,649 | 381 | $7.57 | $12K |
| 99214 Office E&M - Established | Office | 1,563 | 374 | $82.91 | $130K |
| 99231 Hospital E&M - Subsequent | Facility | 611 | 95 | $34.64 | $21K |
| 96372 Injection Administration | Office | 426 | 44 | $9.46 | $4,029 |
| 36415 Venipuncture Blood Collection | Office | 234 | 24 | $8.65 | $2,024 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 233 | 25 | $0.65 | $151 |
| 96367 Intravenous Infusion, Hydration | Office | 203 | 24 | $18.72 | $3,800 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 202 | 30 | $0.94 | $189 |
| 96413 Chemotherapy Administration | Office | 189 | 22 | $82.88 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 182 | 28 | $53.01 | $9,647 |
| 96365 Intravenous Infusion, Hydration | Office | 105 | 15 | $39.28 | $4,124 |
| 99238 Hospital Discharge Management | Facility | 100 | 77 | $54.98 | $5,498 |
| 99222 Hospital E&M - Initial | Facility | 76 | 64 | $91.28 | $6,937 |
By year: 2022 $1.3M for 51,451 services; 2023 $1.2M for 54,315 services; 2024 $1.6M for 65,803 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,649 | 381 | $7.57 | $12K |
| 36415 Venipuncture Blood Collection | 234 | 24 | $8.65 | $2,024 |
| 82274 Immunoassay | 26 | 26 | $15.60 | $406 |
Medicare prescription drug claims, 2024
In 2024, the drug Yusuf K Deshmukh prescribed most often to Medicare patients was Levothyroxine Sodium, with 157 prescriptions and refills. In total Yusuf K Deshmukh wrote 2,647 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 157 | 376 | 39 | $1,814 |
| Pantoprazole Sodium Generic | 122 | 268 | 47 | $1,832 |
| Metoprolol Succinate Generic | 108 | 220 | 29 | $1,107 |
| Lisinopril Generic | 105 | 247 | 35 | $472 |
| Furosemide Generic | 83 | 125 | 33 | $193 |
| Atorvastatin Calcium Generic | 79 | 189 | 26 | $888 |
| Potassium Chloride Generic | 75 | 133 | 30 | $1,765 |
| Eliquis Apixaban | 74 | 115 | 21 | $65K |
| Imatinib Mesylate Generic | 59 | 59 | Under 11 | $243K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 52 | 73 | Under 11 | $1,118 |
| Omeprazole Generic | 51 | 113 | 13 | $590 |
| Amlodipine Besylate Generic | 49 | 131 | 18 | $354 |
| Meloxicam Generic | 47 | 63 | Under 11 | $38.37 |
| Azithromycin Generic | 42 | 42 | 30 | $169 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 40 | 40 | 14 | $443 |
Brand drugs: - claims; generic drugs: 2,274 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yusuf K Deshmukh $2,957 ($2,957 in general payments such as food, travel and fees) from 41 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $387.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $387 |
| Daiichi Sankyo Inc. 4568.T | 10 | $292 |
| Celgene Corporation BMY | 9 | $242 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $156 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 8 | $154 |
| Janssen Biotech, Inc. JNJ | 6 | $147 |
| PharmaEssentia USA Corporation 6446.TW | 6 | $122 |
| Pfizer Inc. PFE | 5 | $109 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.